DeepNoid Inc
KOSDAQ:315640
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its Industry Average (13.9), the stock would be worth ₩-4 119.38 (212% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -12.4 | ₩3 685 |
0%
|
| Industry Average | 13.9 | ₩-4 119.38 |
-212%
|
| Country Average | 8.5 | ₩-2 529.47 |
-169%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
₩107.4B
|
/ |
Oct 2025
₩-8.6B
|
= |
|
|
₩107.4B
|
/ |
Dec 2025
₩8.8B
|
= |
|
|
₩107.4B
|
/ |
Dec 2026
₩22.5B
|
= |
|
|
₩107.4B
|
/ |
Dec 2027
₩8B
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| KR |
D
|
DeepNoid Inc
KOSDAQ:315640
|
108.2B KRW | -12.4 | -11.9 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 21.9 | 53.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
26.8B USD | 20.4 | 29.5 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
14.9B AUD | 77.5 | 62.6 | |
| JP |
|
M3 Inc
TSE:2413
|
1T JPY | 10.2 | 20.8 | |
| SE |
|
Sectra AB
STO:SECT B
|
51.8B SEK | -133.5 | 96.4 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.9B USD | 15.2 | 42.3 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.5B USD | 14.9 | 18.8 | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR | 267.9 | -328 | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
18.6B CNY | -118 | -60.4 | |
| US |
H
|
Heartflow Inc
NASDAQ:HTFL
|
2.8B USD | 0 | 0 |
Market Distribution
| Min | 0 |
| 30th Percentile | 5.3 |
| Median | 8.5 |
| 70th Percentile | 15.6 |
| Max | 24 013.5 |
Other Multiples
DeepNoid Inc
Glance View
Deepnoid, Inc. operates artificial intelligence medical imaging analytics platform. The company is headquartered in Seoul, Seoul and currently employs 115 full-time employees. The company went IPO on 2021-08-17. The firm a virtuous cycle of medical AI ecosystem based on a continuous and integrated all-in-one medical AI platform for accurate and efficient research and an AI clinical decision support system for actual clinical application. The firm's main products include DEEP:AI, DEEP:PHI, DEEP:STORE, and DEEP:PACS.